HAB Pharmaceuticals & Research Limited (HAB Pharma) has appointed Pankaj Agarwal as Chief Financial Officer (CFO), strengthening its financial and organisational leadership as the company works towards its next phase of growth. The appointment comes as HAB Pharma focuses on expanding its manufacturing capabilities, advancing research and development initiatives, strengthening its domestic presence and exploring opportunities in international markets.
A chartered accountant with almost 18 years of experience across the healthcare and pharmaceutical sectors, Agarwal brings expertise in financial strategy, planning and forecasting, financial reporting and compliance, fundraising, treasury management, audit, risk assessment and operational efficiency. Before joining HAB Pharma, he held senior finance positions at Innovcare Lifesciences, Max Healthcare and Vyome Biosciences.
Agarwal has already been associated with HAB Pharma since February 2026. According to the company, his experience during the initial months of his tenure has included working closely with the leadership team and gaining an understanding of the organisation’s business, operations and growth priorities. His appointment as CFO now places him in charge of the company’s broader financial function as HAB Pharma continues to build its operations.
Prior to joining HAB Pharma, Agarwal served in senior finance roles at Innovcare Lifesciences. During his tenure there, he contributed to a US$ 5 million Series C fundraise and a further US$ 1 million raised through non-convertible debentures. He also led the implementation of SAP for the accounts function, adding experience in financial systems and process improvement to his broader finance leadership background.
Earlier in his career, Agarwal worked at Max Healthcare and Vyome Biosciences, building experience across healthcare and life sciences. He began his professional career in audit and compliance with PricewaterhouseCoopers (PwC) and subsequently worked as a Partner at Lahoti Roy & Associates. His career has therefore covered corporate finance, audit, compliance, fundraising, treasury and financial operations across multiple sectors.
In his new role at HAB Pharma, Agarwal will oversee financial planning, budgeting, reporting, compliance, risk management and corporate governance. He will also provide financial insights to support business decision-making while working with the leadership team to strengthen financial discipline, improve operational efficiency and support sustainable value creation across the organisation.
Commenting on the appointment, Saurabh Agarwal, CEO and Director, HAB Pharma, said, “Since joining HAB Pharma in February, Pankaj has brought a strong focus on financial discipline, structured planning and informed decision-making. His understanding of finance, compliance and business operations has been valuable as the company continues to strengthen its manufacturing capabilities, R&D initiatives and market presence. We are confident that his continued contribution will support HAB Pharma’s growth ambitions and help build a stronger financial and governance framework for the organisation.”
Pankaj Agarwal, Chief Financial Officer, HAB Pharma, said, “Over the past six months at HAB Pharma, it has been an enriching experience to work closely with the leadership team and gain a deeper understanding of the company’s business, operations and growth priorities. The organisation is at an important stage of its evolution, with significant opportunities across manufacturing, R&D, exports and domestic markets. I look forward to continuing to strengthen financial processes, improve operational efficiency and support disciplined and sustainable growth.”
Agarwal is a chartered accountant and holds a Post Graduate Executive Management Programme in Finance and Sales from SPJIMR, Mumbai. His combination of financial expertise, pharmaceutical and healthcare sector experience, and exposure to fundraising, financial systems and governance positions him to contribute to HAB Pharma’s financial and operational priorities.
The appointment comes as HAB Pharma, an Indian pharmaceutical company with a legacy spanning more than four decades, continues to strengthen its business across manufacturing, R&D, domestic markets and exports. With Agarwal taking charge as CFO, the company is adding experienced financial leadership to support its growth plans while maintaining focus on financial discipline, compliance, governance and operational efficiency.
 has appointed Pankaj Agarwal as Chief Financial Officer (CFO), strengthening...){kind=link}